Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 39,498,000 | 42,237,000 | 44,033,000 | 47,267,000 | 48,047,000 |
| Cost of Goods | 14,934,000 | 16,768,000 | 16,954,000 | 16,446,000 | 16,871,000 |
| Gross Profit | 24,564,000 | 25,469,000 | 27,079,000 | 30,821,000 | 31,176,000 |
| Operating Expenses | 17,017,000 | 18,786,000 | 19,414,000 | 20,944,000 | 22,200,000 |
| Operating Income | 7,547,000 | 6,683,000 | 7,665,000 | 9,877,000 | 8,976,000 |
| Other Income | -2,146,000 | 10,600,000 | -2,120,000 | -1,138,000 | -1,642,000 |
| Pre-tax Income | 5,401,000 | 17,283,000 | 5,545,000 | 8,739,000 | 7,334,000 |
| Income Tax | 942,000 | 5,349,000 | 1,028,000 | 2,440,000 | 942,000 |
| Net Income Continuous | 4,459,000 | 11,934,000 | 4,517,000 | 6,299,000 | 6,392,000 |
| Minority Interests | 17,000 | 14,000 | 113,000 | 131,000 | 120,000 |
| Net Income | $4,442,000 | $11,920,000 | $4,404,000 | $6,168,000 | $6,272,000 |
| EPS Basic Total Ops | 1.58 | 4.12 | 1.49 | 2.03 | 2.04 |
| EPS Basic Continuous Ops | 1.58 | 4.12 | 1.52 | 2.07 | 2.08 |
| EPS Diluted Total Ops | 1.56 | 4.07 | 1.47 | 2.00 | 2.02 |
| EPS Diluted Continuous Ops | 1.57 | 4.08 | 1.51 | 2.05 | 2.07 |
| EBITDA(a) | $13,922,000 | $13,374,000 | $14,653,000 | $16,855,000 | $16,403,000 |